Use this article to understand why Mounjaro®'s price has increased and what options you have if this affects your treatment.
Use this article when you want to:
Understand why the price of Mounjaro® has increased
See how this price change affects your treatment options
Continue your current Mounjaro® treatment
Decide whether switching to Wegovy® may be right for you
Why Has the Price of Mounjaro® Changed?
Eli Lilly, the manufacturer of Mounjaro®, has increased the price of all Mounjaro® dose strengths in the UK to align with pricing across mainland Europe and other developed markets.
When Mounjaro® first launched in the UK in early 2024, it was priced lower than in other countries to support early access for patients. Eli Lilly has now adjusted Mounjaro®'s pricing to:
Align UK pricing with countries such as Germany and the United States
Support a more consistent global pricing structure for Mounjaro®
Contribute fairly to research and development costs
Aligning prices also helps protect UK supply of Mounjaro® by reducing the risk of the medication being exported to higher-priced markets.
What Are My Options After the Mounjaro® Price Increase?
If this price increase affects your budget, MedExpress offers two main options to help you continue your weight loss treatment safely and effectively.
Option 1: Continue With Mounjaro®
You can continue your current Mounjaro® treatment plan without changes:
Your Mounjaro® dosing schedule remains the same
Your body continues with a medication it is already accustomed to
No additional clinical adjustments are required unless needed
Option 2: Switch to Wegovy®
Wegovy® (semaglutide) is a clinically effective alternative to Mounjaro® that may be more cost-effective. Key points about switching from Mounjaro® to Wegovy®:
Wegovy® is manufactured by Novo Nordisk and is not affected by the Mounjaro® price change
Clinical studies show Wegovy® achieves average weight loss of around 15% over 68 weeks
Your MedExpress clinician will create a safe transition plan based on your current Mounjaro® dose
Switching from Mounjaro® to Wegovy® is a standard clinical process and can be done safely with guidance
Will Switching From Mounjaro® to Wegovy® Affect My Progress?
A temporary adjustment period is normal when switching from Mounjaro® to Wegovy®. However:
Both Mounjaro® and Wegovy® are effective GLP-1 treatments
Your MedExpress clinician will select the appropriate Wegovy® starting dose for you
The goal is to maintain your steady weight loss progress without interruption
MedExpress's Commitment to Your Treatment
MedExpress understands that pricing changes can be frustrating, and is committed to supporting you by providing:
Transparency about pricing changes to Mounjaro®
Flexible options if your treatment needs to change
Clinical support to ensure safe and effective treatment decisions
Need Further Support?
If you still need help after reviewing the information above, additional assistance is available.